169 related articles for article (PubMed ID: 16884920)
1. Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP1(42)) in the absence of an affinity tag.
Shimp RL; Martin LB; Zhang Y; Henderson BS; Duggan P; MacDonald NJ; Lebowitz J; Saul A; Narum DL
Protein Expr Purif; 2006 Nov; 50(1):58-67. PubMed ID: 16884920
[TBL] [Abstract][Full Text] [Related]
2. High-level production and purification of P30P2MSP1(19), an important vaccine antigen for malaria, expressed in the methylotropic yeast Pichia pastoris.
Brady CP; Shimp RL; Miles AP; Whitmore M; Stowers AW
Protein Expr Purif; 2001 Dec; 23(3):468-75. PubMed ID: 11722185
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.
Singh S; Kennedy MC; Long CA; Saul AJ; Miller LH; Stowers AW
Infect Immun; 2003 Dec; 71(12):6766-74. PubMed ID: 14638762
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and expression of 42 kD C-terminal region of the major merozoite surface protein (MSP1 - 42) of P. falciparum 3D7 strain in pichia pastoris].
Zhang D; Pan W; Lu D; Jiang L
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):198-202. PubMed ID: 11953161
[TBL] [Abstract][Full Text] [Related]
5. [Inducible expression of MSP1 gene of Plasmodium falciparum by a tetracycline-controlled promoter].
Qian F; Pan WQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):193-6. PubMed ID: 12567654
[TBL] [Abstract][Full Text] [Related]
6. Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli.
Mazumdar S; Sachdeva S; Chauhan VS; Yazdani SS
Bioprocess Biosyst Eng; 2010 Aug; 33(6):719-30. PubMed ID: 19921275
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
[TBL] [Abstract][Full Text] [Related]
8. Histidine affinity tags affect MSP1(42) structural stability and immunodominance in mice.
Khan F; Legler PM; Mease RM; Duncan EH; Bergmann-Leitner ES; Angov E
Biotechnol J; 2012 Jan; 7(1):133-47. PubMed ID: 22076863
[TBL] [Abstract][Full Text] [Related]
9. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
Darko CA; Angov E; Collins WE; Bergmann-Leitner ES; Girouard AS; Hitt SL; McBride JS; Diggs CL; Holder AA; Long CA; Barnwell JW; Lyon JA
Infect Immun; 2005 Jan; 73(1):287-97. PubMed ID: 15618165
[TBL] [Abstract][Full Text] [Related]
10. Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate.
Bonnet S; Pêtres S; Holm I; Fontaine T; Rosario S; Roth C; Longacre S
Vaccine; 2006 Aug; 24(33-34):5997-6008. PubMed ID: 16814434
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.
Stowers AW; Cioce V; Shimp RL; Lawson M; Hui G; Muratova O; Kaslow DC; Robinson R; Long CA; Miller LH
Infect Immun; 2001 Mar; 69(3):1536-46. PubMed ID: 11179324
[TBL] [Abstract][Full Text] [Related]
12. Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds.
Lau OS; Ng DW; Chan WW; Chang SP; Sun SS
Plant Biotechnol J; 2010 Dec; 8(9):994-1004. PubMed ID: 20444208
[TBL] [Abstract][Full Text] [Related]
13. Orthologous gene sequences of merozoite surface protein 1 (MSP1) from Plasmodium reichenowi and P. gallinaceum confirm an ancient divergence of P. falciparum alleles.
Polley SD; Weedall GD; Thomas AW; Golightly LM; Conway DJ
Mol Biochem Parasitol; 2005 Jul; 142(1):25-31. PubMed ID: 15907558
[TBL] [Abstract][Full Text] [Related]
14. Assistance of maltose binding protein to the in vivo folding of the disulfide-rich C-terminal fragment from Plasmodium falciparum merozoite surface protein 1 expressed in Escherichia coli.
Planson AG; Guijarro JI; Goldberg ME; Chaffotte AF
Biochemistry; 2003 Nov; 42(45):13202-11. PubMed ID: 14609331
[TBL] [Abstract][Full Text] [Related]
15. Production and purification of refolded recombinant Plasmodium falciparum beta-ketoacyl-ACP reductase from inclusion bodies.
Karmodiya K; Srivastav RK; Surolia N
Protein Expr Purif; 2005 Jul; 42(1):131-6. PubMed ID: 15939298
[TBL] [Abstract][Full Text] [Related]
16. Development of pilot scale production process and characterization of a recombinant multiepitope malarial vaccine candidate FALVAC-1A expressed in Escherichia coli.
Ravi G; Ella K; Lakshmi Narasu M
Protein Expr Purif; 2008 Sep; 61(1):57-64. PubMed ID: 18619853
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants.
Sachdeva S; Mohmmed A; Dasaradhi PV; Crabb BS; Katyal A; Malhotra P; Chauhan VS
Vaccine; 2006 Mar; 24(12):2007-16. PubMed ID: 16377036
[TBL] [Abstract][Full Text] [Related]
18. [Recombination and cloning of MSP1(19) and PfCMR of Plasmodium falciparum].
Li X; Yu X; Luo S
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(1):12-5. PubMed ID: 12563808
[TBL] [Abstract][Full Text] [Related]
19. [Specific antibodies against recombinant MSP1 of Plasmodium falciparum strongly inhibit the parasite growth in vitro].
Zhang DM; Pan WQ; Lu DR
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):318-22. PubMed ID: 12019444
[TBL] [Abstract][Full Text] [Related]
20. Production, characterisation and immunogenicity of a plant-made Plasmodium antigen--the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1.
Ma C; Wang L; Webster DE; Campbell AE; Coppel RL
Appl Microbiol Biotechnol; 2012 Apr; 94(1):151-61. PubMed ID: 22170105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
